BABA vs FNKO

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

FNKO exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. The company is struggling with negative revenue growth (-7.00% YoY) and a deeply negative ROE of -32.33%, suggesting an inability to generate returns from equity. While the Price/Sales ratio of 0.23 appears attractive, it is likely a value trap given the deteriorating profitability and bearish insider sentiment. The combination of declining sales and high debt-to-equity (1.57) creates a high-risk profile.